COMMUNIQUÉS West-GlobeNewswire

1104Health and Johns Hopkins Researchers Present Data on Physician Collaboration Across Community and Academic Oncology
27/10/2026
Across 24 oncology organizations, findings highlight new physician relationships, rapid access to subspecialty expertise, and changes in patient management BALTIMORE, Oct. 27, 2026 (GLOBE NEWSWIRE) -- 1104Health, which [...]
Les Canadiens souhaitent assister à des événements sportifs féminins professionnels. La plupart des amateurs ignorent cependant où les trouver.
27/10/2026
Une nouvelle étude de Femmes et sport au Canada révèle que la demande est avérée, mais que le manque de visibilité freine la prochaine phase de croissance du marché TORONTO, 27 oct. 2026 (GLOBE NEWSWIRE) -- Trois [...]
Canadians Want Professional Women’s Sport. Most Fans Don’t Know Where to Find it.
27/10/2026
New Canadian Women & Sport research finds demand is proven, but visibility is holding back the market’s next phase of growth TORONTO, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Three in four Canadians (75%) now identify as [...]
Four Years After St. Paul Acquisition, Pro-Tech Design & Manufacturing Shows Medtech Consolidation Doesn't Have to Mean Disruption
27/10/2026
The St. Paul facility has shipped more than 3.5 million medical devices since joining Pro-Tech Design in 2022, while retaining 100% of its customers and 95% of its employees St. Paul, MN, Oct. 27, 2026 (GLOBE NEWSWIRE [...]
Bavarian Nordic to Supply and Donate Vaccines for Global Mpox Emergency Stockpile
27/10/2026
Bavarian Nordic donates 75,000 doses of MVA-BN ® and will also supply 150,000 doses to new global mpox vaccine emergency stockpile. Building emergency reserves is an important milestone in global mpox preparedness, [...]
Addition Therapeutics to Present Preclinical Data from PRINT™ Programs at the European Society of Gene & Cell Therapy’s (ESGCT) 33rd Annual Congress
27/10/2026
Addition continues to progress a novel pipeline of non-viral, LNP-delivered, RNA-only gene-addition therapies for severe, lifelong genetic and non-genetic diseases Company to present an oral presentation on the PRINT [...]
UK health tech pioneer Patients Know Best launches global expansion at HLTH Las Vegas
27/10/2026
Cambridge, UK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Patients Know Best (PKB) , the UK patient-controlled health record platform, will exhibit at HLTH Las Vegas (15–18 November, The Venetian Expo) as part of the UK [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 septembre 2026
27/10/2026
DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l’article 222-12-5 du règlement général de l’AMF, les [...]
CDT Partners with Manoira to Explore Enhancing Animal Health Products Ahead of Launch
27/10/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Oct. 27, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) ("CDT" or the "Company"), today announced that it has entered into an evaluation agreement with Manoira [...]
Entera Appoints Global Research and Development Leader Dr. Juan Camilo Arjona Ferreira to Its Board of Directors
27/10/2026
Dr. Arjona Ferreira currently serves as Head of Research and Development and Chief Medical Officer at Organon & Co. (NYSE: OGN) He joins Entera with two decades of clinical development, regulatory execution, and [...]
vTv Therapeutics Announces First Participant Randomized in Phase 2a Pilot Study Evaluating Cadisegliatin in Individuals with Type 1 Diabetes (T1D) Using Hybrid Closed-Loop (HCL) Insulin Delivery Systems
27/10/2026
Phase 2a pilot study aims to inform the design and conduct of future Phase 3 research in this population Cadisegliatin is a potential first-in-class oral therapy being evaluated as an adjunct to insulin for the [...]
Stryker to participate in the 2026 Jefferies Global Healthcare Conference
27/10/2026
Portage, Michigan, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2026 Jefferies Global Healthcare Conference on Tuesday, November 17, 2026 , at the Waldorf Hilton and ME Hotel in London. [...]
Enlivex Announces Receipt of Delisting Notice from Nasdaq; Intends to Appeal
27/10/2026
Nes-Ziona, Israel, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV) ("Enlivex" or the "Company"), a quality longevity company powered by a prediction markets treasury, today announced receipt of a delisting [...]
Inhibikase Therapeutics Announces Participation in Upcoming Investor Conferences During November 2026
27/10/2026
WILMINGTON, Del., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing IKT-001, a novel once-daily oral anti- [...]
Altimmune Appoints Peter Greenleaf and Alex Howarth, Two Leading Biotech Executives, to Board of Directors to Support Its Strategic Evolution
27/10/2026
Board appointments align with successful transition to late-stage clinical Company developing pemvidutide as a differentiated liver franchise with multiple potential indications As part of this transition, John M. Gill [...]
AssistRx Named a Central Florida Top Workplace for Sixth Consecutive Year
27/10/2026
Employee feedback-based recognition highlights AssistRx’s focus on growth, inclusion and wellness ORLANDO, Fla., Oct. 27, 2026 (GLOBE NEWSWIRE) -- AssistRx , the advanced therapy initiation and patient solutions [...]
Legend Biotech to Host Investor Conference Call on Third Quarter 2026 Results
27/10/2026
BRIDGEWATER N.J., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 a.m. ET on Tuesday, [...]
Madrigal to Present Multiple Abstracts at AASLD's The Liver Meeting 2026, Including New Real-World Evidence Reinforcing Rezdiffra as a Foundational Therapy for MASH
27/10/2026
Rezdiffra ® (resmetirom) to be featured in more abstracts than any other approved or investigational MASH therapy Real-world evidence abstracts examine Rezdiffra effectiveness, tolerability and treatment persistence in [...]
Calidi Biotherapeutics Presented New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026, Including Highlighting the Potential of its RedTail Gene Medicine Platform to Turn Tumors into Localized TCE Biofactories
27/10/2026
Single-dose CLD-401 induced tumor regression and complete response in 80% of mice in EMT6 breast tumor model Building on the growing clinical evidence supporting T-cell engagers in solid tumors, data showed the platform [...]

Pages

Other news

Test 2

22/10/2026

Lorem ipsum

Test 1

22/10/2026

Lorem upsum